3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
25
Ovarian Neoplasms
19
Neoplasms
12
Fallopian Tube Neoplasms
12
Carcinoma, Hepatocellular
11
Endometrial Neoplasms
7
Neoplasm Metastasis
6
Colonic Neoplasms
6
Carcinoma, Non-Small-Cell Lung
6
Glioblastoma
4
Brain Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Rectal Neoplasms
3
Lung Neoplasms
3
Liver Neoplasms
3
Digestive System Neoplasms
3
Uterine Cervical Neoplasms
2
Sarcoma
2
Recurrence
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Mouth Neoplasms
2
Lymphoid Interstitial Pneumonia
2
Intestinal Neoplasms
2
Gastrointestinal Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Ovarian Epithelial
2
Brenner Tumor
2
Breast Neoplasms
2
Biliary Tract Neoplasms
2
Astrocytoma
2
Interventions
Cytarabine
5
Whole-Body Irradiation
3
Specimen Handling
3
Injections
3
CPX-351
3
Blood Specimen Collection
3
venetoclax
2
luspatercept
2
ivosidenib
2
fludarabine phosphate
2
fludarabine
2
decitabine and cedazuridine drug combination
2
Tacrolimus
2
Peripheral Blood Stem Cell Transplantation
2
Mycophenolic Acid
2
Melphalan
2
Liposomes
2
Idarubicin
2
Granulocyte Colony-Stimulating Factor
2
Gemtuzumab
2
Filgrastim
2
Daunorubicin
2
Cyclosporine
2
Cyclophosphamide
2
Busulfan
2
Biopsy
2
Azacitidine
2
tocilizumab
1
selinexor
1
ruxolitinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myeloproliferative Disorders
×
Bevacizumab
×
30 days
×
Clear all
No trials found.